Home/Filings/4/0001493152-18-009767
4//SEC Filing

DHILLON AVTAR S 4

Accession 0001493152-18-009767

CIK 0001444307other

Filed

Jul 5, 8:00 PM ET

Accepted

Jul 6, 4:40 PM ET

Size

23.6 KB

Accession

0001493152-18-009767

Insider Transaction Report

Form 4
Period: 2018-06-15
DHILLON AVTAR S
Director10% Owner
Transactions
  • Exercise/Conversion

    Common Stock

    2018-06-15+100,000181,002 total
  • Sale

    Common Stock

    2018-06-18$1.39/sh5,552$7,695175,450 total
  • Sale

    Common Stock

    2018-06-21$1.40/sh2,178$3,051160,461 total
  • Sale

    Common Stock

    2018-06-25$1.41/sh202$284157,303 total
  • Sale

    Common Stock

    2018-06-26$1.40/sh4,703$6,575152,600 total
  • Sale

    Common Stock

    2018-06-29$1.38/sh1,066$1,471146,527 total
  • Sale

    Common Stock

    2018-07-05$1.31/sh3,100$4,067143,427 total
  • Sale

    Common Stock

    2018-06-19$1.36/sh1,838$2,507173,612 total
  • Sale

    Common Stock

    2018-06-20$1.42/sh10,973$15,604162,639 total
  • Sale

    Common Stock

    2018-06-22$1.42/sh2,956$4,192157,505 total
  • Sale

    Common Stock

    2018-06-27$1.37/sh3,451$4,742149,149 total
  • Sale

    Common Stock

    2018-06-28$1.40/sh1,556$2,180147,593 total
  • Exercise/Conversion

    Restricted Stock Units

    2018-06-15100,0000 total
    From: 2019-03-04Exp: 2019-03-04Common Stock (100,000 underlying)
Footnotes (2)
  • [F1]Each restricted stock unit represents the contingent right to receive one share of common stock upon vesting of the unit.
  • [F2]Sale to cover taxes on restricted stock unit vesting.

Documents

1 file

Issuer

ONCOSEC MEDICAL Inc

CIK 0001444307

Entity typeother

Related Parties

1
  • filerCIK 0001260933

Filing Metadata

Form type
4
Filed
Jul 5, 8:00 PM ET
Accepted
Jul 6, 4:40 PM ET
Size
23.6 KB